The role of symbolic gestures in the path towards auditory rehabilitation of infants with hearing loss: a feasibility study

You have accessThe ASHA LeaderBottom Line1 Nov 2008Coding and Reimbursement for Auditory Rehabilitation Steven C WhitePhD, CCC-A Steven C White Google Scholar More articles by this author , PhD, CCC-A https://doi.org/10.1044/leader.BML.13162008.3 SectionsAbout ToolsAdd to favorites ShareFacebookTwitterLinked In For many years audiologists and speech-language pathologists have billed for auditory rehabilitation services—services described as aural rehabilitation or audiologic rehabilitation. The Current Procedural Terminology© (CPT) code descriptor will serve as a guide for this update regarding coding, coverage, and reimbursement of auditory rehabilitation. Q: How and why have the CPT codes changed over the past five years? Originally “aural rehabilitation” was included in the descriptor of speech-language pathology evaluation (92506) and speech-language pathology treatment (92507 individual and 92508 group). Audiologists found it difficult to receive reimbursement from private health plans because plans interpreted the codes as for use only by SLPs. ASHA collaborated with other audiology organizations and proposed deleting “aural rehabilitation” from 92506, 92507, and 92508 and creating new codes for auditory rehabilitation evaluation and auditory rehabilitation. The ASHA Health Care Economics Committee, with the help of audiologist Robert C. Fifer (University of Miami, Fla.), developed recommendations for new codes. In 2006 new CPT codes for auditory rehabilitation evaluation and auditory rehabilitation included: 92626, evaluation of auditory rehabilitation status, first hour; 92627, each additional 15 minutes 92630, auditory rehabilitation, prelingual hearing loss 92633, auditory rehabilitation, postlingual hearing loss Q: How does Medicare approach auditory rehabilitation? Medicare covers auditory rehabilitation evaluation supplied by either audiologists or SLPs. Medicare does not recognize 92630 or 92633 because audiology is a diagnostic-only service under the statute. Medicare also prohibits SLPs from using these codes. SLPs can bill 92507 and 92508 even though “aural rehabilitation” is not in the descriptor. Q: What are the Medicare relative values for auditory rehabilitation evaluation procedures? Medicare uses the resource-based relative value scale to establish its annual physician fee schedule, which includes audiology and speech-language pathology procedures. Audiologists and SLPs can find Medicare fee schedules on the Billing and Reimbursement pages of the ASHA Web site. Each procedure includes three components—professional (physician work), technical (practice expense), and professional liability (malpractice)—and each component receives relative value units (RVUs). In 2008, CPT 92626—auditory rehabilitation evaluation—has zero professional work RVUs, 2.10 practice expense RVUs, and 0.06 malpractice RVUs for a total of 2.16 RVUs. The total is multiplied by the Medicare 2008 conversion factor of 38.0870 for a national fee of $82.27. Practitioners can check with their Medicare contractor for the local rates. The ASHA Medicare fee schedules include a link to the Centers for Medicare and Medicaid Services (CMS) Web site that allows local rate determinations. The RVUs for 92627—each additional 15 minutes—are zero professional work RVUs, 0.50 practice expense RVUs, and 0.02 malpractice RVUs for a total of 0.52 RVUs. The total RVUs multiplied by the Medicare conversion factor result in a national rate of $19.81. There are no RVUs for auditory rehabilitation procedures 92630 or 92633 because Medicare does not cover audiology treatment services. Q: Will these procedures have a “professional work” component in the future? We believe so. ASHA, the American Academy of Audiology, and the American Academy of Otolaryngology–Head and Neck Surgery presented recommended data for professional work to the American Medical Association RVU Update Committee (RUC). Following the RUC review, CMS will consider it for the 2010 Medicare Physician Fee Schedule. The audiologist’s time is now included in the practice expense in the auditory rehabilitation evaluation procedures. The value for that time will be removed because it will be part of the professional component. The rehabilitation treatment codes will have no RVUs at all for Medicare. Q: Do private health plans cover audiologists or SLPs providing auditory rehabilitation? Each private health plan develops its own coverage position, often available on the Internet. For example, CIGNA posts its position 0180, which provides different coverage for audiology and speech-language pathology aspects of auditory rehabilitation and lists the four CPT codes described in this column. Aetna’s clinical policy bulletin 0034 is somewhat cryptic and states that the company “considers aural rehabilitation medically necessary as speech therapy.” Aetna lists the auditory rehabilitation codes but includes a related CPT code—69930, cochlear device implantation. Audiologists should contact ASHA (at [email protected]) if they experience problems with private health plan coverage of auditory rehabilitation services. Professionals may bill both 92507 (treatment of speech, language, voice—individual) and an auditory rehabilitation code if they are providing speech production and auditory training services during the same session. Q: Aetna includes the cochlear implantation code. Does that mean that payers restrict coverage to services for those patients with cochlear implants and not hearing aids? That should not be the case but coverage may be restricted to a change in the patient’s hearing—that is, there is no pre-existing condition. We always recommend you contact the payer. When dealing with Medicare, contact the Medicare administrative contractor, fiscal intermediary, or carrier. Author Notes Steven C White, PhD, CCC-A, director of health care economics and advocacy, can be reached at [email protected]. Advertising Disclaimer | Advertise With Us Advertising Disclaimer | Advertise With Us Additional Resources FiguresSourcesRelatedDetails Volume 13Issue 16November 2008 Get Permissions Add to your Mendeley library History Published in print: Nov 1, 2008 Metrics Current downloads: 712 Topicsasha-topicsleader_do_tagasha-article-typesleader-topicsCopyright & Permissions© 2008 American Speech-Language-Hearing AssociationLoading ...

Cochlear Implant Coding

Are Cochlear Implants a Viable Option Following Temporal Bone Fracture?

Cochlear implantation is an effective method for the treatment of severe and very severe sensorineural hearing loss. However, there are differences in the effect of rehabilitation. By analyzing and summarizing the related literatures, this paper sums up the influencing factors of the rehabilitation of auditory and speech rehabilitation after cochlear implantation. Implantation age and postoperative rehabilitation training are considered to be the main factors that affect the speech and speech rehabilitation. With the development of gene diagnosis and molecular biology, exploring the internal relationship between gene mutation and cochlear implantation has become the focus of research. Through gene diagnosis, we can make clear the molecular etiology of patients, and analyze other related factors, which can provide the basis for clinicians to evaluate the effect of hearing and speech rehabilitation after cochlear implantation. Key words: Cochlear Implantation; Hearing Loss, Sensorineural; Rehabilitation of Speech and Language Disorders; Genes

Objective:To investigatethe effection of white matter abnormality to auditory and speech rehabilitation after cochlear implantation in prelingual deafness children.Method:Thirty-five children with white matter abnormality were included in this study. The degree of leukoaraiosis was evaluated by Scheltens scale based on MRI.The hearing and speechrecovery level was rated by auditory behavior grading standards(CAP) and speech intelligibility grading standards(SIR) at 6 months, 12 months, and 24 months post operation. Result:The CAP scores and SIR scores of the children with white matter abnormality were lower than those of the control group at 6 months after operation (P<0.05).The SIR scores of the children with white matter abnormality at 12 months and 24 months post operation were significantly lower than those of the control group.There was no statistically significant difference between the CAP scores of the two groups at 12 and 24 months after operation(P>0.05).Schelten classification had a greater impact on SIR scores than on CAP scores. Conclusion:The effect of white matter abnormality on auditory and speech rehabilitation after cochlear implantation was related to the degree of leukoencephalopathy. When the lesion of white matter abnormality was larger, the level of hearing and verbal rehabilitation was lower, and the speech rehabilitation was more significantly impacted by white matter lesions degree.

Clinical Practice Guideline: Sudden Hearing Loss (Update) Executive Summary.

Clinical Practice Guideline: Sudden Hearing Loss (Update).

A cochlear implant (CI) is a hearing device introduced in the 1980s for profoundly deaf subjects who gained little or no benefit from powerful hearing aids. This device comprises an electrode array inserted in the cochlea, connected to an internal receiver, and an externally worn speech processor. The CI transforms acoustic signals into electrical currents which directly stimulate the auditory nerve. Since the early 1990s, cochlear implantation in children has been developing rapidly. Although it is still difficult to predict how a child will perform with a cochlear implant, the success of cochlear implantation can no longer be denied. In this paper, some recent papers and reports, and the results of the various Nijmegen cochlear implant studies, are reviewed. Issues about selection, examinations, surgery and the outcome are discussed. Overall, our results were comparable with those of other authors. It can be concluded that cochlear implantation is an effective treatment for postlingually deaf as well as prelingually (congenital or acquired) deaf children with profound bilateral sensorineural deafness.

Objective: To explore the perioperative precautions, rehabilitation effect, and affecting factors in cochlear implantation (CI) among patients with hereditary syndromic hearing loss. Methods: This was a retrospective cohort study. 47 patients diagnosed as hereditary syndromic deafness were treated in the Department of Otolaryngology-Head and Neck Surgery of the Chinese PLA General Hospital from 2010 to 2021, including 26 males and 21 females, aged 0.9-25 years. All patients received unilateral or bilateral CI. Clinical manifestation combined with genetic testing was used to diagnose syndromic hearing loss. The risks and precautions of CI in these patients were summarized from preoperative imaging, intraoperative observations, and postoperative complications. Single factor linear regression and multiple linear regression models in SPSS 26.0 software were used to evaluate the effects of various factors on auditory and speech rehabilitation after CI for syndromic hearing loss. The postoperative outcomes were analyzed through aided hearing thresholds, categories of auditory performance (CAP) scale, and speech intelligibility rate (SIR) scale. Results: Thirteen kinds of syndromes, totally 47 cases, including CHARGE (20 cases), Waardenburg (9 cases), Autosomal dominant deafness-onychodystrophy (DDOD, 4 cases), Pendred (3 cases), Noonan Syndrome with Multiple Lentigines (NSML, 2 cases), Branchio-Oto-Renal (BOR, 2 cases), Bart-Pumphery (1 case), Perrault (1 case), Kabuki (1 case), Frontometaphyseal dysplasia type 2 (FMD 2, 1 case), Mandibulofacial dysostosis Guion-Almeida type (MFDGA, 1 case), Coffin-Siris (1 case), and 10q26.12-q26.3 del (1 case), were enrolled. The perioperative special management included the following measures. For patients with cardiac and/or cartilage development issues, preoperative assessments of cardiac function and/or laryngeal cartilage development were performed to minimize anesthetic risks. For patients with mild intellectual disability and/or an auditory neuropathy phenotype, preoperative communication with the patients' families was conducted to explain the limitations of CI and assist in setting reasonable expectations. For syndromic hearing loss patients who commonly present with inner ear malformations, facial nerve anomalies, and/or intraoperative cerebrospinal fluid leakage, appropriate electrodes were selected prior to surgery, intraoperative facial nerve monitoring and careful cerebrospinal fluid leak repair were conducted, respectively. For patients with NSML accompanied by coagulation issues, the postoperative compression bandaging duration was extended to reduce the risk of hematoma formation. The daily duration of cochlear implant use, the presence of cochlear malformation, and developmental delay were independent factors influencing postoperative CAP scores. The daily duration of cochlear implant use, developmental delay, and unilateral or bilateral CI were independent factors influencing postoperative SIR scores. Conclusions: Hereditary syndrome deafness is a rare disease that affects multiple organs and causes extensive functional impairment. Before CI, a comprehensive evaluation of major affected organ functions is required to assess anesthetic and surgical risks. Genetic diagnosis not only identifies the molecular etiology of patients with syndromic hearing loss and reveals rare phenotypes, but also aids in prognostic evaluation. The main factors affecting CI outcomes in patients with syndromic hearing loss include the presence of cochlear malformations, developmental delays, daily duration of cochlear implant use, and bilateral implantation status.

Music to the Impaired or Implanted Ear

You have accessThe ASHA LeaderBottom Line1 May 2008Auditory Implants: Coding and Reimbursement Issues Steven C White Steven C White Google Scholar More articles by this author https://doi.org/10.1044/leader.BML.13062008.3 SectionsAbout ToolsAdd to favorites ShareFacebookTwitterLinked In The topic of cochlear implants, middle-ear implants, and brain-stem implants is an active one in the coding and reimbursement of audiology and speech-language pathology evaluation and treatment services. Specific Current Procedural Terminology (CPT) codes are related to testing and rehabilitation for prospective implant patients and patients who have received an implant. Robert Fifer and other members of ASHA’s Health Care Economics Committee have drafted and defended CPT proposals to the American Medical Association CPT Editorial Panel to ensure that appropriate codes are available to audiologists and speech-language pathologists to report auditory implant device-related procedures. These questions and answers focus on coverage and procedural coding of these services. Q: I am an audiologist and am seeing a Medicare beneficiary for auditory rehabilitation following a cochlear implant. Can I bill Medicare for CPT 92633 (auditory rehabilitation; postlingual hearing loss)? No. Medicare covers only diagnostic audiology services. The Medicare statute needs to be amended to permit audiologists to bill for rehabilitation services. ASHA is working to accomplish that goal. Q: I am an SLP and work in a hospital. Can the hospital bill Medicare for CPT 92633 (auditory rehabilitation; postlingual hearing loss) when I provide the procedure? No. Although SLPs can provide Medicare rehabilitation services, the Centers for Medicare and Medicaid Services (CMS) made the decision not to cover 92633—and also not to cover CPT 92630, auditory rehabilitation; prelingual hearing loss—to clarify that audiologists could not bill for the procedure. CMS instructs SLPs providing auditory rehabilitation to Medicare beneficiaries to use CPT 92507 (treatment of speech, language, voice, communication, and/or auditory processing). Q: Can the hospital, my employer, bill a private health plan (e.g., an employer-sponsored health plan) for CPT 92633 when I provide the service? I’m an SLP. The hospital definitely can bill a private health plan for CPT 92633. Only Medicare disallows CPT 92633. You may want to check the health plan’s Web site to ensure that 92633 is included in its medical policy. For example, Cigna has a Healthcare Coverage Position (0180) that specifically lists 92630 and 92633 as covered procedures when medically necessary (search “aural rehabilitation” on Cigna’s Web site). The summary of the Cigna coverage position states, “AR is indicated for the treatment of such impairment and is a medically necessary component of the management of cochlear device and auditory brainstem implantation.” Q: As an audiologist in private practice, can I bill a private health plan (e.g., an employer-sponsored health plan) for CPT 92633 when I provide the service? Yes, you can bill a private health plan for CPT 92633. Only Medicare disallows CPT 92633. As stated above, you may want to check the health plan’s Web site to ensure that 92633 is included in its medical policy. The Cigna policy is a good one for you to review to see how private health plans view AR. Q: I am a private-practice audiologist and have a Medicare provider number. What CPT code should I use when seeing a 15-year-old patient who has just had a cochlear implant? The code for this situation is CPT 92603 (diagnostic analysis of cochlear implant, age 7 years or older; with programming). For follow-up services you can use CPT 92604 (subsequent reprogramming). Q: I recently took a position as an audiologist in an auditory implant center. Is there a code for programming an auditory brainstem implant? I know Medicare covers the surgery. The correct code is CPT 92640 (diagnostic analysis with programming of auditory brainstem implant, per hour). Author Notes Steven C White, director of health care economics and advocacy, can be reached at [email protected]. Advertising Disclaimer | Advertise With Us Advertising Disclaimer | Advertise With Us Additional Resources FiguresSourcesRelatedDetails Volume 13Issue 6May 2008 Get Permissions Add to your Mendeley library History Published in print: May 1, 2008 Metrics Downloaded 443 times Topicsasha-topicsleader_do_tagleader-topicsasha-article-typesCopyright & Permissions© 2008 American Speech-Language-Hearing AssociationLoading ...

Hearing loss can lead to long-lasting effects on the central nervous system, and current therapies, such as auditory training and rehabilitation, show mixed success in improving perception and speech comprehension. Vagus nerve stimulation (VNS) is an adjunctive therapy that can be paired with rehabilitation to facilitate behavioral recovery after neural injury. However, VNS for auditory recovery has not been tested after severe hearing loss or significant damage to peripheral receptors. This study investigated the utility of pairing VNS with passive or active auditory rehabilitation in a rat model of noise-induced hearing loss. Although auditory rehabilitation helped rats improve their frequency discrimination, learn novel speech discrimination tasks, and achieve speech-in-noise performance similar to normal hearing controls, VNS did not enhance recovery of speech sound perception. These results highlight the limitations of VNS as an adjunctive therapy for hearing loss rehabilitation and suggest that optimal benefits from neuromodulation may require restored peripheral signaling.

Sudden Sensorineural Hearing Loss: Otolaryngologic and Audiologic Options

Cochlear implantation (CI) is used for rehabilitation of children with bilateral severe to profound permanent childhood hearing loss (PCHL). Recently, treatment of such children has been influenced by diagnostic technological advances. Children with perinatal risk factors associated with PCHL can undergo CI. The primary aim of this study was to determine the effects of 'perinatal risk factor associated with PCHL' on post-CI auditory outcomes. In this prospective study at a tertiary care centre we evaluated 50 cochlear implanted children from October 2011 to March 2013. The case group consisted of 6 (12%) children who had presence of 'perinatal risk factor associated with PCHL' and control group consisted of 44 (88%) children without any 'perinatal risk factor associated with PCHL'. All patients received auditory and speech rehabilitation and we evaluated their auditory perception outcomes by categories of auditory performance (CAP) and meaningful auditory integration scale (MAIS) scores at 1year post-CI. There were significantly decreased mean MAIS scores (decrease of 8.6%) and mean CAP scores (decrease of 6.7%) in CI recipient children with 'perinatal risk factor associated with PCHL' as compared to those who were without any 'perinatal risk factor associated with PCHL' at 1year after CI. However, in children with 'perinatal risk factor associated with PCHL', mean CAP & MAIS scores (auditory perception outcomes) were still more than 80% of maximum achievable CAP & MAIS scores. In this study, CI recipient children who were without any 'perinatal risk factor associated with PCHL' had significantly better mean MAIS & CAP scores (auditory perception outcomes) 1year post-CI. However, even in children who had 'perinatal risk factor associated with PCHL', there was substantial improvement in auditory perception outcomes at 1year post-CI and CI was still helpful in these children. Hence, knowledge of 'perinatal risk factor associated with PCHL' can provide reasonable help in predicting the auditory perception outcome and optimal counselling of families of CI candidates.

Grounded in Self-Determination Theory, this study examines the role of parental expectations and communication style (ie, in an autonomy-supportive vs controlling way) in the prediction of adolescent motivation (ie, internalization or defiance) to adhere to self-management for type 1 diabetes. Structural Equation Modeling was used in a cross-sectional, multi-informant study of 129 adolescents (Mage = 14.43; 54.4% girls), 110 mothers, and 98 fathers. Adolescents reported on self-motivation, treatment adherence, and parental expectations and communication styles; parents reported on their own expectations, communication style, and perceptions of adolescent treatment adherence. Medical record review provided HbA1c values. Across adolescent and parent reports, parental communication of diabetes-specific expectations and an autonomy-supportive style of communicating expectations related positively to adolescents' internalization of diabetes self-management and negatively to defiance against diabetes self-management. In contrast, a controlling parental communication style showed the opposite patterns of associations. Higher adolescent defiance was related to poorer treatment adherence and worse glycemic control. Parental communication styles related to adolescent motivation, which in turn, related to adolescent treatment adherence and glycemic control. Future longitudinal research can address the long-term impact of both maternal and paternal communication styles on adolescent motivation to adhere to treatment and their subsequent glycemic control.